Odyssey Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the standard of care for patients with autoimmune and inflammatory diseases. Founded in 2021, the company focuses on developing small molecule and protein therapeutics that precisely target disease pathology. By concentrating on upstream signaling nodes and mechanisms within the innate immune system, Odyssey aims to prevent pathological inflammation before it occurs, differentiating its approach from existing treatments that address inflammation after it has initiated.